Patent Assignment
Reel/Frame 040164/0294
Merger
Recorded: 2016-10-29
Pages: 4
Assignor
XETRIOS THERAPEUTICS, INC.
Executed: 2016-08-09
Assignee
KOLLTAN PHARMACEUTICALS, INC.
300 GEORGE STREET, SUITE 530, NEW HAVEN, CONNECTICUT, 06511
Covered Property
(1)
Regulating the Interaction Between Tam Ligands and Lipid Membranes with Exposed Phosphatidyl Serine
Application:
15/270,813 →
Publication:
US 2017/0129947
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 29, 2016
From: FRITZ, LAWRENCE C.; VOLLRATH, BENEDIKT
To: XETRIOS THERAPEUTICS, INC.
Reel/Frame 040164/0282 →
Assignment of Assignor's Interest
Oct 29, 2016
From: LEMKE, GREG E.; ROTHLIN, CARLA V.
To: SALK INSTITUTE FOR BIOLOGICAL STUDIES
Reel/Frame 040164/0290 →
Merger
Feb 3, 2017
From: KOLLTAN PHARMACEUTICALS, INC.
To: KOLLTAN, LLC
Reel/Frame 041172/0443 →
Merger
Feb 3, 2017
From: KOLLTAN, LLC
To: CELLDEX THERAPEUTICS, INC.
Reel/Frame 041172/0468 →